Protagenic Therapeutics I...

AI Score

0

Unlock

0.28
-0.02 (-8.20%)
At close: Mar 03, 2025, 3:59 PM
0.50
81.32%
After-hours: Mar 03, 2025, 07:59 PM EST

Protagenic Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 85K 40.03M 69.09M 113.88M 36.98M 18.72M n/a n/a n/a 18.57M 21.63M 21.39M 18.76M 15.62M 12.57M 9.9M 6.9M
Cost of Revenue 28.22K 30.00 n/a 286.00 339.00 347.00 148.00 534.00 n/a n/a n/a 42.71M 53.87M 84.29M 5.01M 597K n/a n/a n/a 10.55M 12.27M 11.78M 10.96M 7.8M 6.74M 5.1M 3.4M
Gross Profit -28.22K -30 n/a -286 -339 -347 -148 -534 n/a n/a 85K -2.68M 15.22M 29.59M 31.97M 18.12M n/a n/a n/a 8.03M 9.36M 9.6M 7.8M 7.81M 5.83M 4.8M 3.5M
Operating Income -4.53M -3.56M -4.14M -2.55M -2.09M -2.31M -2.37M -2.23M -491K -975K -673K -22.3M -28.86M -117.09M -5.5M 1.47M -94.47K -2.23M -7.9M -528K 747K 1.83M -275K 866K -661K -700K -1M
Interest Income 156.79K 185.79K 33.21K 502.00 2.81K 2.79K 13.89K 907.00 n/a n/a n/a 10K 72K 748K 464K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income -5M -3.56M -4.52M -2.55M -1.75M -2.56M -2.26M -2.28M -501K -924K -806K -20.61M -28.86M -116.64M -5.07M 1.39M n/a -1.33M n/a -834K 307K 1.34M n/a n/a n/a -500K -800K
Net Income -5M -3.6M -4.99M -2.79M -1.77M -2.56M -2.26M -2.28M -476K -1.08M -1.03M -19.73M -29.47M -115.77M -4.15M 677K -94.47K -2.23M -7.9M -728K 144K 1.14M -674K 648K -858K -300K -600K
Selling & General & Admin 1.21M 1.97M 3M 1.85M 1.28M 1.43M 1.65M 1.41M 491K 975K 758K 13.12M 23.09M 26.03M 37.47M 16.65M 94.47K n/a n/a 8.55M 8.61M 7.77M 8.08M 6.95M 6.5M 5.1M 4.1M
Research & Development 3.32M 1.59M 1.14M 699.8K 807.95K 881.19K 717.45K 417.87K 464.45 42K 337.31 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses 0.00 n/a n/a n/a n/a n/a n/a 404.17K n/a n/a n/a 1.64M 3.7M 5.87M n/a n/a n/a -2.23M -7.9M n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 4.53M 3.56M 4.14M 2.55M 2.09M 2.31M 2.37M 1.83M 491K 975K 758K 14.77M 26.79M 31.9M 37.47M 16.65M 94.47K -2.23M -7.9M 8.55M 8.61M 7.77M 8.08M 6.95M 6.5M 5.1M 4.1M
Interest Expense n/a 137.46K 496.91K 246.18K 15.89K 2.79K 13.89K 7.16K 18K 3K n/a 16K 76K 147K 22K 14K n/a n/a n/a 306K 440K 496K n/a n/a 197K -200K -200K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a 115.83K n/a n/a n/a 4.04M 8.39M 9.97M 24.99M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 4.53M 3.56M 4.14M 2.55M 2.09M 2.31M 2.37M 1.83M 491K 975K 758K 57.47M 80.66M 116.19M 42.48M 17.25M 94.47K -2.23M -7.9M 19.1M 20.88M 19.55M 19.04M 14.75M 13.23M 10.2M 7.5M
Income Tax n/a 46.05K 463.7K 246.18K 15.89K 486.81K -105.69K 440.24K -33K 101K 354K -1.07M 640K -852K -1.2M 708K 94.47K 907K n/a -106K 163K 203K 399K 218K 197K -200K -200K
Shares Outstanding (Basic) 4.34M 4.32M 3.69M 2.58M 2.57M 2.57M 2.57M 1.33M 6.5K 6.47K 1.63K 102.00 84.00 86.00 49.00 1.00 1.00 4.24M 4.24M 1.00 1.00 1.00 1.00 1.00 1.00 4.24M 4.24M
Shares Outstanding (Diluted) 4.34M 4.32M 3.69M 2.58M 2.57M 2.57M 2.57M 1.33M 6.5K 6.5K 1.63K 102.00 84.00 86.00 49.00 1.00 1.00 4.24M 4.24M 1.00 1.00 1.00 1.00 1.00 1.00 4.24M 4.24M
EPS (Basic) -1.15 -0.83 -1.35 -1.08 -0.69 -1 -0.88 -1.72 -73.23 -166.86 -632 -193.4K -350.83K -1.35M -84.67K 677K -94.47K -0.53 -1.86 -728K 144K 1.14M -674K 648K -858K -0.07 -0.14
EPS (Diluted) -1.15 -0.83 -1.35 -1.08 -0.69 -1 -0.88 -1.72 -73.23 -166 -632 -193.4K -350.83K -1.35M -84.67K 677K -94.47K -0.53 -1.86 -728K 144K 1.14M -674K 648K -858K -0.07 -0.14
EBITDA -4.5M -3.42M -4.14M -2.55M -2.09M -2.31M -2.37M -2.27M -1.02M -347K -806K -19.35M -25.09M -110.63M -3.7M 1.57M 675K -1.33M -5.41M 1.57M 2.77M 3.73M 1.64M 2.41M 462K 350K 100K
Depreciation & Amortization 28.22K 30.00 286.00 286.00 339.00 347.00 148.00 534.00 1K 0.38 1.20 1.64M 3.7M 5.87M 1.35M 25K n/a n/a 2.49M 2.09M 2.03M 1.89M 1.91M 1.55M 1.12M 1.05M 1.1M